National Health Investors (NHI) Expected to Announce Quarterly Earnings on Monday

Key Points

• National Health Investors (NHI) will report Q1 2026 results after the close on May 4; analysts forecast $0.855 EPS and $70.22M revenue, and the company has set FY2026 guidance of $4.94–$4.99 EPS.
• The REIT declared a quarterly dividend of $0.92 per share (annualized $3.68) for a ~4.8% yield, though its dividend payout ratio is elevated at 121.85%.
• Shares opened near $76.97 with a 12‑month range of $68.80–$91.38; Wall Street ratings are mixed but the consensus is a "Moderate Buy" with an average price target of $87.50.

National Health Investors (NYSE:NHI - Get Free Report) is projected to announce its Q1 2026 results after the market closes on Monday, May 4th. Analysts expect the company to announce earnings of $0.8550 per share and revenue of $70.2160 million for the quarter. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Investors can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 10:00 AM ET.

National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.01). National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The company had revenue of $105.82 million for the quarter, compared to the consensus estimate of $95.12 million. During the same period in the prior year, the company earned $1.24 earnings per share. The firm's revenue was up 6.8% on a year-over-year basis. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Stock Down 0.0%

National Health Investors stock opened at $76.97 on Monday. National Health Investors has a twelve month low of $68.80 and a twelve month high of $91.38. The firm has a 50 day moving average price of $84.81 and a 200-day moving average price of $80.46. The company has a market capitalization of $3.73 billion, a P/E ratio of 25.49, a P/E/G ratio of 4.20 and a beta of 0.63. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.76.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors's dividend payout ratio is currently 121.85%.

Wall Street Analyst Weigh In

NHI has been the subject of several research reports. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a "buy" rating to a "hold" rating and set a $85.00 price target for the company. in a research note on Tuesday, January 20th. Cantor Fitzgerald reiterated an "overweight" rating and set a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd. Weiss Ratings reiterated a "buy (b)" rating on shares of National Health Investors in a research note on Friday, March 27th. Wells Fargo & Company cut their price target on National Health Investors from $86.00 to $84.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 22nd. Finally, Truist Financial cut their price objective on shares of National Health Investors from $92.00 to $89.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, National Health Investors presently has an average rating of "Moderate Buy" and a consensus price target of $87.50.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of NHI. Freestone Grove Partners LP bought a new position in National Health Investors in the 4th quarter valued at $21,869,000. Adage Capital Partners GP L.L.C. bought a new stake in shares of National Health Investors during the 4th quarter valued at about $19,856,000. Balyasny Asset Management L.P. boosted its position in shares of National Health Investors by 66.9% during the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust's stock valued at $43,121,000 after acquiring an additional 246,486 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of National Health Investors by 481.3% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust's stock valued at $18,792,000 after acquiring an additional 195,716 shares during the last quarter. Finally, Qube Research & Technologies Ltd boosted its position in shares of National Health Investors by 86.0% during the 2nd quarter. Qube Research & Technologies Ltd now owns 319,286 shares of the real estate investment trust's stock valued at $22,388,000 after acquiring an additional 147,591 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.